Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−27.28 USD
−637.32 M USD
2.67 B USD
19.15 M
About Bio-Rad Laboratories, Inc.
Sector
Industry
CEO
Norman D. Schwartz
Website
Headquarters
Hercules
Founded
1952
FIGI
BBG000DY28W5
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
BIO5368765
Bio-Rad Laboratories, Inc. 3.7% 15-MAR-2032Yield to maturity
5.72%
Maturity date
Mar 15, 2032
BIO5368763
Bio-Rad Laboratories, Inc. 3.3% 15-MAR-2027Yield to maturity
4.86%
Maturity date
Mar 15, 2027
Explore more bonds
Frequently Asked Questions
The current price of BIO is 323.03 USD — it has increased by 0.94% in the past 24 hours. Watch Bio-Rad Laboratories, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Bio-Rad Laboratories, Inc. stocks are traded under the ticker BIO.
BIO stock has fallen by −10.92% compared to the previous week, the month change is a −5.84% fall, over the last year Bio-Rad Laboratories, Inc. has showed a 4.77% increase.
We've gathered analysts' opinions on Bio-Rad Laboratories, Inc. future price: according to them, BIO price has a max estimate of 469.00 USD and a min estimate of 315.00 USD. Watch BIO chart and read a more detailed Bio-Rad Laboratories, Inc. stock forecast: see what analysts think of Bio-Rad Laboratories, Inc. and suggest that you do with its stocks.
BIO stock is 0.20% volatile and has beta coefficient of 0.53. Track Bio-Rad Laboratories, Inc. stock price on the chart and check out the list of the most volatile stocks — is Bio-Rad Laboratories, Inc. there?
Today Bio-Rad Laboratories, Inc. has the market capitalization of 9.06 B, it has decreased by −7.60% over the last week.
Yes, you can track Bio-Rad Laboratories, Inc. financials in yearly and quarterly reports right on TradingView.
Bio-Rad Laboratories, Inc. is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
BIO earnings for the last quarter are 2.01 USD per share, whereas the estimation was 1.16 USD resulting in a 73.70% surprise. The estimated earnings for the next quarter are 2.86 USD per share. See more details about Bio-Rad Laboratories, Inc. earnings.
Bio-Rad Laboratories, Inc. revenue for the last quarter amounts to 649.73 M USD, despite the estimated figure of 628.18 M USD. In the next quarter, revenue is expected to reach 681.29 M USD.
BIO net income for the last quarter is 653.17 M USD, while the quarter before that showed −2.17 B USD of net income which accounts for 130.16% change. Track more Bio-Rad Laboratories, Inc. financial stats to get the full picture.
No, BIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 8.03 K employees. See our rating of the largest employees — is Bio-Rad Laboratories, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bio-Rad Laboratories, Inc. EBITDA is 540.96 M USD, and current EBITDA margin is 21.57%. See more stats in Bio-Rad Laboratories, Inc. financial statements.
Like other stocks, BIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bio-Rad Laboratories, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bio-Rad Laboratories, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bio-Rad Laboratories, Inc. stock shows the sell signal. See more of Bio-Rad Laboratories, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.